David Oakes - Publications

Affiliations: 
University of Rochester, Rochester, NY 
Area:
Biostatistics Biology, Statistics

90 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Zareba W, Daubert JP, Beck CA, Huang DT, Alexis JD, Brown MW, Pyykkonen K, McNitt S, Oakes D, Feng C, Aktas MK, Ayala-Parades F, Baranchuk A, Dubuc M, Haigney M, et al. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial. Journal of the American College of Cardiology. 72: 636-645. PMID 30071993 DOI: 10.1016/j.jacc.2018.04.086  0.92
2013 Oakes D. An introduction to survival models: In honor of Ross Prentice Lifetime Data Analysis. 19: 442-462. PMID 23832309 DOI: 10.1007/s10985-013-9276-2  1
2013 Killoran A, Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, Young AB, Shoulson I. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology. 80: 2022-7. PMID 23624566 DOI: 10.1212/WNL.0b013e318294b304  1
2013 Moss AJ, Greenberg H, Dwyer EM, Klein H, Ryan D, Francis C, Marcus F, Eberly S, Benhorin J, Bodenheimer M, Brown M, Case R, Gillespie J, Goldstein R, Haigney M, ... ... Oakes D, et al. Senior academic physicians and retirement considerations. Progress in Cardiovascular Diseases. 55: 611-5. PMID 23621971 DOI: 10.1016/j.pcad.2013.02.002  1
2013 Wills AM, Eberly S, Tennis M, Lang AE, Messing S, Togasaki D, Tanner CM, Kamp C, Chen JF, Oakes D, McDermott MP, Schwarzschild MA. Caffeine consumption and risk of dyskinesia in CALM-PD. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 380-3. PMID 23339054 DOI: 10.1002/mds.25319  1
2013 Marras C, Oakes D. Author reply to Holford, Vu and Nutt regarding 'piecing together the puzzle of progression and mortality in Parkinson's disease' British Journal of Clinical Pharmacology. 75: 1372. PMID 22989073 DOI: 10.1111/j.1365-2125.2012.04464.x  1
2012 Frampton MW, Bausch J, Chalupa D, Hopke PK, Little EL, Oakes D, Stewart JC, Utell MJ. Effects of outdoor air pollutants on platelet activation in people with type 2 diabetes Inhalation Toxicology. 24: 831-838. PMID 23033996 DOI: 10.3109/08958378.2012.724117  1
2012 Ravina B, Marek K, Eberly S, Oakes D, Kurlan R, Ascherio A, Beal F, Beck J, Flagg E, Galpern WR, Harman J, Lang AE, Schwarzschild M, Tanner C, Shoulson I. Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1392-7. PMID 22976926 DOI: 10.1002/mds.25157  1
2012 Paumier KL, Siderowf AD, Auinger P, Oakes D, Madhavan L, Espay AJ, Revilla FJ, Collier TJ. Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 880-7. PMID 22555881 DOI: 10.1002/mds.24978  1
2012 Marras C, Oakes D. Piecing together the puzzle of progression and mortality in Parkinson's disease British Journal of Clinical Pharmacology. 74: 264-266. PMID 22554391 DOI: 10.1111/j.1365-2125.2012.04315.x  1
2012 Rich DQ, Zareba W, Beckett W, Hopke PK, Oakes D, Frampton MW, Bisognano J, Chalupa D, Bausch J, O'Shea K, Wang Y, Utell MJ. Are ambient ultrafine, accumulation mode, and fine particles associated with adverse cardiac responses in patients undergoing cardiac rehabilitation? Environmental Health Perspectives. 120: 1162-1169. PMID 22542955 DOI: 10.1289/ehp.1104262  1
2011 Dorsey R, Biglan K, Eberly S, Auinger P, Brocht A, Umeh CC, Oakes D, Clarence-Smith K, Marshall F, Shoulson I, Frank S. Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study. Plos Currents. 3: RRN1283. PMID 22139861 DOI: 10.1371/currents.RRN1283  1
2011 Huang X, Auinger P, Eberly S, Oakes D, Schwarzschild M, Ascherio A, Mailman R, Chen H. Serum cholesterol and the progression of parkinson's disease: Results from DATATOP Plos One. 6. PMID 21853051 DOI: 10.1371/journal.pone.0022854  1
2011 Schwarzschild MA, Marek K, Eberly S, Oakes D, Shoulson I, Jennings D, Seibyl J, Ascherio A. Serum urate and probability of dopaminergic deficit in early "Parkinson's disease". Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1864-8. PMID 21538532 DOI: 10.1002/mds.23741  1
2010 Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, Poleshuck EL, Stodgell CJ, Dworkin RH. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstetrics and Gynecology. 116: 583-93. PMID 20733439 DOI: 10.1097/AOG.0b013e3181e9e0ab  1
2010 Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I, Shoulson I, Hyson C, Oakes D, Flagg E, Rudolph A, Kieburtz K, et al. Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1801-8. PMID 20669311 DOI: 10.1002/mds.23006  1
2010 Oakes D, Feng C. Combining stratified and unstratified log-rank tests in paired survival data Statistics in Medicine. 29: 1735-1745. PMID 20572124 DOI: 10.1002/sim.3921  1
2010 Meng H, Wamsley BR, Friedman B, Liebel D, Dixon DA, Gao S, Oakes D, Eggert GM. Impact of body mass index on the effectiveness of a disease management-health promotion intervention on disability status. American Journal of Health Promotion : Ajhp. 24: 214-22. PMID 20073389 DOI: 10.4278/ajhp.081216-QUAN-306  1
2009 Marras C, Lang AE, Eberly SW, Oakes D, Fahn S, Schwid SR, Hyson C, Shoulson I. A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 2370-8. PMID 19908310 DOI: 10.1002/mds.22828  1
2009 Hauser RA, Auinger P, Oakes D. Levodopa response in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 2328-36. PMID 19908302 DOI: 10.1002/mds.22759  1
2009 Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, ... Oakes D, et al. Urate as a predictor of the rate of clinical decline in Parkinson disease. Archives of Neurology. 66: 1460-8. PMID 19822770 DOI: 10.1001/archneurol.2009.247  1
2009 Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, et al. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 2081-90. PMID 19691116 DOI: 10.1002/mds.22690  1
2009 Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, Stodgell CJ, Dworkin RH. The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsiveness. Obstetrics and Gynecology. 113: 825-32. PMID 19305326 DOI: 10.1097/AOG.0b013e31819bda7c  1
2009 Saperstein S, Chen L, Oakes D, Pryhuber G, Finkelstein J. IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 29: 273-84. PMID 19231998 DOI: 10.1089/jir.2008.0076  1
2009 Constantinescu R, Romer M, Oakes D, Rosengren L, Kieburtz K. Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease. Parkinsonism & Related Disorders. 15: 245-8. PMID 19056308 DOI: 10.1016/j.parkreldis.2008.05.012  1
2008 Oster E, Dorsey ER, Bausch J, Shinaman A, Kayson E, Oakes D, Shoulson I, Quaid K. Fear of health insurance loss among individuals at risk for Huntington disease. American Journal of Medical Genetics. Part A. 146: 2070-7. PMID 18627059 DOI: 10.1002/ajmg.a.32422  1
2008 Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Clinical Neuropharmacology. 31: 127-33. PMID 18520979 DOI: 10.1097/WNF.0b013e3180ca77ea  1
2008 Oakes D, Peterson DR. Survival methods: additional topics. Circulation. 117: 2949-55. PMID 18519862 DOI: 10.1161/CIRCULATIONAHA.107.700377  1
2008 Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A, Hyson C, Gorbold E, Rudolph A, Kieburtz K, Fahn S, Gauger L, et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Archives of Neurology. 65: 716-23. PMID 18413464 DOI: 10.1001/archneur.2008.65.6.nct70003  1
2008 Oakes D. On consistency of Kendall's tau under censoring Biometrika. 95: 997-1001. DOI: 10.1093/biomet/asn037  1
2008 Wang A, Oakes D. Some properties of the Kendall distribution in bivariate Archimedean copula models under censoring Statistics and Probability Letters. 78: 2578-2583. DOI: 10.1016/j.spl.2008.07.018  1
2007 Johnson SA, Stout JC, Solomon AC, Langbehn DR, Aylward EH, Cruce CB, Ross CA, Nance M, Kayson E, Julian-Baros E, Hayden MR, Kieburtz K, Guttman M, Oakes D, Shoulson I, et al. Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease. Brain : a Journal of Neurology. 130: 1732-44. PMID 17584778 DOI: 10.1093/brain/awm107  1
2007 Solomon AC, Stout JC, Johnson SA, Langbehn DR, Aylward EH, Brandt J, Ross CA, Beglinger L, Hayden MR, Kieburtz K, Kayson E, Julian-Baros E, Duff K, Guttman M, Nance M, ... Oakes D, et al. Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia. 45: 1767-76. PMID 17303196 DOI: 10.1016/j.neuropsychologia.2006.12.015  1
2006 Paulsen JS, Hayden M, Stout JC, Langbehn DR, Aylward E, Ross CA, Guttman M, Nance M, Kieburtz K, Oakes D, Shoulson I, Kayson E, Johnson S, Penziner E. Preparing for preventive clinical trials: the Predict-HD study. Archives of Neurology. 63: 883-90. PMID 16769871 DOI: 10.1001/archneur.63.6.883  1
2006 Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW. Head injury and Parkinson's disease risk in twins. Annals of Neurology. 60: 65-72. PMID 16718702 DOI: 10.1002/ana.20882  1
2006 Goetz CG, Schwid SR, Eberly SW, Oakes D, Shoulson I. Safety of rasagiline in elderly patients with Parkinson disease. Neurology. 66: 1427-9. PMID 16682679 DOI: 10.1212/01.wnl.0000210692.95595.1c  1
2006 Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, Shoulson I. Rasagiline improves quality of life in patients with early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 616-23. PMID 16450340 DOI: 10.1002/mds.20764  1
2005 Chou KL, Messing S, Oakes D, Feldman PD, Breier A, Friedman JH. Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments. Clinical Neuropharmacology. 28: 215-9. PMID 16239760 DOI: 10.1097/01.wnf.0000180228.77802.32  1
2005 Moss AJ, Ryan D, Oakes D, Goldstein RE, Greenberg H, Bodenheimer MM, Brown MW, Case RB, Dwyer EM, Eberly SW, Francis CW, Gillespie JA, Krone RJ, Lichstein E, MacCluer JW, et al. Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction. The American Journal of Cardiology. 96: 177-82. PMID 16018837 DOI: 10.1016/j.amjcard.2005.03.039  1
2005 Hogarth P, Kayson E, Kieburtz K, Marder K, Oakes D, Rosas D, Shoulson I, Wexler NS, Young AB, Zhao H. Interrater agreement in the assessment of motor manifestations of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 293-7. PMID 15584032 DOI: 10.1002/mds.20332  1
2005 Oakes D. On the preservation of copula structure under truncation Canadian Journal of Statistics. 33: 465-468.  1
2004 Jennings DL, Seibyl JP, Oakes D, Eberly S, Murphy J, Marek K. (123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. Archives of Neurology. 61: 1224-9. PMID 15313838 DOI: 10.1001/archneur.61.8.1224  1
2004 Shults CW, Haas R, Oakes D, Kieburtz K, Plumb S, Shoulson I, Beal MF, Juncos J, Nutt J. Measuring the effects of therapy in Parkinson disease. Jama. 291: 2430-1; author reply. PMID 15161889 DOI: 10.1001/jama.291.20.2430-b  1
2004 Manatunga AK, Oakes D. Efficiency of independence working analysis of correlated survival data with general cluster size Statistica Neerlandica. 58: 313-321. DOI: 10.1111/j.1467-9574.2004.00124.x  1
2003 Reider CR, Halter CA, Castelluccio PF, Oakes D, Nichols WC, Foroud T. Reliability of reported age at onset for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 275-9. PMID 12621630 DOI: 10.1002/mds.10391  1
2003 Howard CR, Howard FM, Lanphear B, Eberly S, deBlieck EA, Oakes D, Lawrence RA. Randomized clinical trial of pacifier use and bottle-feeding or cupfeeding and their effect on breastfeeding. Pediatrics. 111: 511-8. PMID 12612229 DOI: 10.1542/peds.111.3.511  1
2003 Oakes D, Wang A. Copula model generated by Dabrowska's association measure Biometrika. 90: 478-481. DOI: 10.1093/biomet/90.2.478  1
2002 McDermott MP, Hall WJ, Oakes D, Eberly S. Design and analysis of two-period studies of potentially disease-modifying treatments. Controlled Clinical Trials. 23: 635-49. PMID 12505242 DOI: 10.1016/S0197-2456(02)00238-6  1
2002 Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Archives of Neurology. 59: 1541-50. PMID 12374491 DOI: 10.1001/archneur.59.10.1541  1
2002 Harb TS, Zareba W, Moss AJ, Ridker PM, Marder VJ, Rifai N, Miller Watelet LF, Arora R, Brown MW, Case RB, Dwyer EM, Gillespie JA, Goldstein RE, Greenberg H, Hochman J, ... ... Oakes D, et al. Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction. The American Journal of Cardiology. 89: 216-21. PMID 11792346 DOI: 10.1016/S0002-9149(01)02204-4  1
2001 Factor SA, Friedman JH, Lannon MC, Oakes D, Bourgeois K. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial Movement Disorders. 16: 135-139. PMID 11215574 DOI: 10.1002/1531-8257(200101)16:1<135::AID-MDS1006>3.0.CO;2-Q  1
2001 Oakes D. Biometrika centenary: Survival analysis Biometrika. 88: 99-142.  1
2000 Marek K, Seibyl J, Holloway R, Kieburtz K, Oakes D, Lang A. A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism Neurology. 55: 1540-1547. PMID 11094111  1
2000 Miller Watelet LF, Moss AJ, Zareba W, Oakes D, Ryan D. Detection of a group of risk factors in coronary disease using a new carriership analysis approach American Journal of Cardiology. 86: 1253-1256. PMID 11090802 DOI: 10.1016/S0002-9149(00)01213-3  1
2000 Oakes D, Ritz J. Regression in a bivariate copula model Biometrika. 87: 345-352.  1
1999 Manatunga AK, Oakes D. Parametric Analysis for Matched Pair Survival Data Lifetime Data Analysis. 5: 371-387. PMID 10650743 DOI: 10.1023/A:1009692210273  1
1999 Shetty N, Friedman JH, Kieburtz K, Marshall FJ, Oakes D. The placebo response in Parkinson's disease Clinical Neuropharmacology. 22: 207-212. PMID 10442249  1
1999 Oakes D. Direct calculation of the information matrix via the EM algorithm Journal of the Royal Statistical Society. Series B: Statistical Methodology. 61: 479-482.  1
1998 Oakes D, Jeong JH. Frailty Models and Rank Tests Lifetime Data Analysis. 4: 209-228. PMID 9787603  1
1998 Lin DY, Oakes D, Ying Z. Additive hazards regression with current status data Biometrika. 85: 289-298.  1
1997 Oakes D. Selegiline and excess mortality Clinical Neuropharmacology. 20: 542. PMID 9403228  1
1997 LeWitt P, Oakes D, Cui L. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α-tocopherol Movement Disorders. 12: 183-189. PMID 9087976 DOI: 10.1002/mds.870120208  1
1997 Emond MJ, Ritz J, Oakes D. Bias in gee estimates from misspecified models for longitudinal data Communications in Statistics - Theory and Methods. 26: 15-32.  1
1996 Maki-Ikola O, Heinonen E, Penney JB, Shoulson I, Kieburtz K, Oakes D. Study design problems of DATATOP study analysis [2] Annals of Neurology. 40: 946-948. PMID 9007106 DOI: 10.1002/ana.410400624  1
1996 Manatunga AK, Oakes D. A measure of association for bivariate frailty distributions Journal of Multivariate Analysis. 56: 60-74. DOI: 10.1006/jmva.1996.0004  1
1995 Oakes D. Multiple time scales in survival analysis Lifetime Data Analysis. 1: 7-18. PMID 9385093 DOI: 10.1007/BF00985253  1
1992 Boden WE, Moss AJ, Oakes D. Hypolipidemic effect of type Ia antiarrhythmic agents in postinfarction patients Circulation. 85: 2039-2044. PMID 1591822  1
1992 Oakes D, Manatunga AK. A new representation of Cox's score statistic and its variance Statistics and Probability Letters. 14: 107-110. DOI: 10.1016/0167-7152(92)90072-D  1
1990 Benhorin J, Moss AJ, Oakes D. Prognostic significance of nonfatal myocardial reinfarction Journal of the American College of Cardiology. 15: 253-258. PMID 2299062  1
1990 Oakes D, Dasu T. A note on residual life Biometrika. 77: 409-410. DOI: 10.1093/biomet/77.2.409  1
1990 Jackson Hall W, Oakes D. Statistical issues in monitoring a 2 × 2 factorial clinical trial Controlled Clinical Trials. 11: 264.  1
1990 Oakes D, McDermott M, Eberly S, Plumb S, Watts A, Shoulson I. ·P-17 Investigator effects in a multicenter trial for parkinson's disease Controlled Clinical Trials. 11: 284.  1
1989 Moss AJ, Oakes D, Benhorin J, Carleen E. The interaction between diltiazem and left ventricular function after myocardial infarction Circulation. 80. PMID 2688978  1
1988 Dubach P, Froelicher VF, Klein J, Oakes D, Grover-McKay M, Friis R. Exercise-induced hypotension in a male population: Criteria, causes, and prognosis Circulation. 78: 1380-1387. PMID 3191592  1
1988 Stewart S, Alexson C, Manning J, Oakes D, Eberly SW. Long-term palliation with the classic Blalock-Taussig shunt Journal of Thoracic and Cardiovascular Surgery. 96: 117-121. PMID 2455199  1
1986 Oakes D. Semiparametric inference in a model for association in bivanate survival data Biometrika. 73: 353-361. DOI: 10.1093/biomet/73.2.353  1
1985 Bazas T, Oakes D, Gilson JC, Bazas B, McDonald JC. Pleural calcification in northwest Greece Environmental Research. 38: 239-247. PMID 4065074 DOI: 10.1016/0013-9351(85)90088-X  1
1985 Newhouse ML, Oakes D, Woolley AJ. Mortality of welders and other craftsmen at a shipyard in NE England. British Journal of Industrial Medicine. 42: 406-10. PMID 4005194  1
1985 Douglas DB, Douglas RB, Oakes D, Scott G. Pulmonary function of London firemen British Journal of Industrial Medicine. 42: 55-58. PMID 3965016  1
1984 Harrington JM, Oakes D. Mortality study of British pathologists 1974-80 British Journal of Industrial Medicine. 41: 188-191. PMID 6722045  1
1983 Oakes D. Comparison of models for survival data Statistics in Medicine. 2: 305-311. PMID 6648145  1
1983 Oakes D. Survival analysis European Journal of Operational Research. 12: 3-14. DOI: 10.1016/0377-2217(83)90177-7  1
1982 Oakes D, Douglas R, Knight K, Wusteman M, Mcdonald JC. Respiratory effects of prolonged exposure to gypsum dust Annals of Occupational Hygiene. 26: 833-840. PMID 7181310 DOI: 10.1093/annhyg/26.8.833  1
1982 Oakes D, McDonald JC. Restricted cohort study designs Scandinavian Journal of Work, Environment and Health. 8: 30-33. PMID 7100853  1
1982 Armstrong BG, Oakes D. Effects of approximation in exposure assessments on estimates of exposure-response relationships Scandinavian Journal of Work, Environment and Health. 8: 20-23. PMID 7100851  1
1982 Fawer RF, Ward Gardner A, Oakes D. Absences attributed to respiratory diseases in welders British Journal of Industrial Medicine. 39: 149-152. PMID 7066231  1
1977 Oakes D. Stochastic backtrackings Stochastic Processes and Their Applications. 6: 95-111. DOI: 10.1016/0304-4149(77)90021-7  1
1977 Oakes D. The asymptotic information in censored survival data Biometrika. 64: 441-448.  1
1976 Oakes D. Bivariate Markov processes of intervals Information and Control. 32: 231-241. DOI: 10.1016/S0019-9958(76)90236-9  1
1974 Daley DJ, Oakes D. Random walk point processes Zeitschrift FüR Wahrscheinlichkeitstheorie Und Verwandte Gebiete. 30: 1-16. DOI: 10.1007/BF00532859  1
Show low-probability matches.